CERE

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Cerevel Therapeutics Holdings, Inc. - CERE

Why Cerevel Therapeutics Is Up More Than 29% in the First Half of 2021

Here's What's Pushing Cerevel Therapeutics Stock Lower Today

Cerevel Therapeutics Announces Pricing of $350 Million Public Offering of Common Stock

CERE Stock: The Huge News That Has Cerevel Therapeutics Skyrocketing

CERE Stock Price Increases Over 60% Pre-Market: Why It Happened

Cerevel Therapeutics Holdings, Inc. (CERE) CEO Tony Coles on Q1 2021 Results - Earnings Call Transcript